SCHEMBL17992070

SCHEMBL17992070

OCNc1ccccc1CNC1=Nc2ccccc2NC12CCOCC2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17992106 0.89 POLB (0.32) —
SCHEMBL17757494 0.88 — —
SCHEMBL17992079 0.88 ACAT2 (0.37) —
SCHEMBL17992024 0.87 — —
SCHEMBL19523188 0.86 STAT6 (0.38) —
SCHEMBL17757325 0.84 PIK3CA (0.39) —
SCHEMBL17757225 0.84 HDAC3 (0.34) —
SCHEMBL17757324 0.84 CYP2A13 (0.36) —
SCHEMBL17757337 0.84 CYP2A13 (0.36) —
SCHEMBL17758060 0.84 STAT6 (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9802956-B2 Spiroquinoxaline derivatives as inhibitors of non-apoptotic regulated cell-death HELMHOLTZ ZENTRUM MUNCHEN-DEUTSCHES FORSCHUNGSZENTRUM FUR GESUNDHEIT UND UMWELT (GMBH) (DE) 2017-10-31 — — US disclosed
US-20160222025-A1 SPIROQUINOXALINE DERIVATIVES AS INHIBITORS OF NON-APOPTOTIC REGULATED CELL-DEATH HELMHOLTZ ZENTRUM MUNCHEN (DE) 2016-08-04 — — US disclosed
Send feedback